Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 129Colonic Neoplasms 54Rectal Neoplasms 48Carcinoma, Hepatocellular 29Stomach Neoplasms 23Neoplasm Metastasis 23Neoplasms 11Pancreatic Neoplasms 10Cholangiocarcinoma 9Adenocarcinoma Of Esophagus 8Esophageal Neoplasms 7Liver Neoplasms 6Gastrointestinal Neoplasms 5Biliary Tract Neoplasms 5Recurrence 4Ovarian Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Esophageal Squamous Cell Carcinoma 3Digestive System Neoplasms 3Breast Neoplasms 3Adenocarcinoma 3Unresectable Metastatic Colorectal Cancer 2Peritoneal Neoplasms 2Neurotoxicity Syndromes 2Neoplastic Cells, Circulating 2Intestinal Neoplasms 2Gastrointestinal Diseases 2Gallbladder Neoplasms 2Colorectal Cancer Metastatic 2Cirrhosis, Familial, with Pulmonary Hypertension 2

Interventions

Immune Checkpoint Inhibitors 1Folfox protocol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Locally Advanced Colorectal Carcinoma × Folfox protocol × Clear all
NCT06154538 2025-11-28

Immune Checkpoint Inhibitors + Chemotherapy Versus Chemotherapy in the Neoadjuvant Treatment of Locally Advanced Colorectal Cancer

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Phase 2 Recruiting
170 enrolled
Gastrointestinal

Locally Advanced Colorectal Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡